Related references
Note: Only part of the references are listed.SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT
J. Doerr et al.
NEUROLOGY (2009)
Analysis of Ordered Categorical Data: Two Score-Independent Approaches
Gang Zheng
BIOMETRICS (2008)
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
Syed Khizer Hasan et al.
BLOOD (2008)
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
Emmanuelle Le Page et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician
Aaron Boster et al.
LANCET NEUROLOGY (2008)
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression
Manfred Uhr et al.
NEURON (2008)
Cubic exact solutions for the estimation of pairwise haplotype frequencies:: implications for linkage disequilibrium analyses and a web tool 'CubeX'
Tom R. Gaunt et al.
BMC BIOINFORMATICS (2007)
A second generation human haplotype map of over 3.1 million SNPs
Kelly A. Frazer et al.
NATURE (2007)
Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis
Richard E. Gonsette
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
F. Paul et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
ABCG2: determining its relevance in clinical drug resistance
Robert W. Robey et al.
CANCER AND METASTASIS REVIEWS (2007)
Inhibition by mitoxantrone of in vitro migration of immunocompetent cells -: A possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis
Tea Kopadze et al.
ARCHIVES OF NEUROLOGY (2006)
Role of drug efflux carriers in the healthy and diseased brain
Dirk M. Hermann et al.
ANNALS OF NEUROLOGY (2006)
Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane
E Bernitsas et al.
ANNALS OF NEUROLOGY (2006)
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
L Wojnowski et al.
CIRCULATION (2005)
Drug resistance in brain diseases and the role of drug efflux transporters
W Löscher et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients
A Chan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Human breast cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine
P Pavek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2
S Mizuarai et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Mitoxantrone treatment of multiple sclerosis - Safety considerations
BA Cohen et al.
NEUROLOGY (2004)
The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis
FX Weilbach et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Escalating immunotherapy of multiple sclerosis -: New aspects and practical application
C Bassetti et al.
JOURNAL OF NEUROLOGY (2004)
Diagnostic criteria for multiple sclerosis: an historical review
CM Poser et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2004)
Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon-beta
A Chan et al.
GLIA (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Choice of scores in trend tests for case-control studies of candidate-gene associations
G Zheng et al.
BIOMETRICAL JOURNAL (2003)
Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
HP Hartung et al.
LANCET (2002)
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS
RG Ghalie et al.
NEUROLOGY (2002)
The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
M Hitzl et al.
PHARMACOGENETICS (2001)
Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation
N von Ahsen et al.
THROMBOSIS RESEARCH (2000)
Share Paper
